Acadia Pharmaceuticals (ACAD) PT Raised to $15 at Jefferies
Tweet
Share
E-mailGet Alerts ACAD Hot Sheet
Price: $28.85 -0.89%
Rating Summary:
17 Buy, 10 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 11 | New: 25
Rating Summary:
17 Buy, 10 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 11 | New: 25
Join SI Premium – FREE
Jefferies analyst Chris Howerton raised the price target on Acadia Pharmaceuticals (NASDAQ: ACAD) to $15.00 (from $10.00) while maintaining a Underperform rating.
You May Also Be Interested In
- BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $109 at Raymond James
- Mixue Group (2097:HK) PT Lowered to HK$285 at Goldman Sachs
- PayPal (PYPL) PT Lowered to $53 at Truist Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
